NCT05652686 2025-09-23A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)Phanes TherapeuticsPhase 1/2 Recruiting203 enrolled
NCT06698965 2024-11-21Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and CarboplatinShanghai Chest HospitalPhase 2 Recruiting52 enrolled